3 in prostate cancer cells. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy13

Prostate Cell Line, Tumor Tumor Cells, Cultured Epithelial Cells Neoplastic Stem Cells HCT116 Cells Cell Nucleus MCF-7 Cells HT29 Cells Cell Line Stromal Cells Neoplastic Cells, Circulating Chromosomes, Human, Pair 8

Organisms4

Mice, Nude Mice, SCID Mice, Inbred BALB C Adenoviridae

Diseases29

Prostatic Neoplasms Neoplasms, Hormone-Dependent Neoplasm Invasiveness Neoplasm Metastasis Prostatic Hyperplasia Breast Neoplasms Adenocarcinoma Bone Neoplasms Disease Progression Prostatic Intraepithelial Neoplasia Neoplasms Colonic Neoplasms Lung Neoplasms Carcinoma Ovarian Neoplasms Genetic Predisposition to Disease Pancreatic Neoplasms Cell Transformation, Neoplastic Stomach Neoplasms Prostatic Neoplasms, Castration-Resistant Neovascularization, Pathologic Neoplasm Recurrence, Local Urinary Bladder Neoplasms Colorectal Neoplasms Neoplastic Cells, Circulating Disease Models, Animal Prostatic Diseases Carcinoma, Non-Small-Cell Lung Uterine Cervical Neoplasms

Chemicals and Drugs100

Prostate-Specific Antigen Receptors, Androgen Androgens Androgen Antagonists Antineoplastic Agents Tosyl Compounds Androgen Receptor Antagonists Metribolone RNA, Small Interfering RNA, Messenger Neoplasm Proteins Anilides Tumor Markers, Biological Dihydrotestosterone Testosterone Congeners Anticarcinogenic Agents Proto-Oncogene Proteins c-akt Antineoplastic Agents, Phytogenic Antineoplastic Agents, Hormonal Glutamate Carboxypeptidase II PTEN Phosphohydrolase Tumor Suppressor Protein p53 Flutamide Nitriles DNA, Neoplasm Taxoids Proto-Oncogene Proteins c-bcl-2 Transcription Factors RNA, Neoplasm Caspases Enzyme Inhibitors Finasteride Tumor Suppressor Proteins MicroRNAs Proto-Oncogene Proteins Caspase 3 Apoptosis Regulatory Proteins Isothiocyanates DNA-Binding Proteins TNF-Related Apoptosis-Inducing Ligand Cyclin-Dependent Kinase Inhibitor p21 Antigens, Neoplasm Receptor, erbB-2 Protein-Serine-Threonine Kinases Cancer Vaccines Plant Extracts DNA Primers 5-alpha Reductase Inhibitors Organoselenium Compounds Phosphatidylinositol 3-Kinases Inhibitor of Apoptosis Proteins Paclitaxel NF-kappa B Receptor, Epidermal Growth Factor Receptors, Estrogen Cadherins Testosterone Poly(ADP-ribose) Polymerases Cell Cycle Proteins Protein Kinase Inhibitors Gossypol Phenylthiohydantoin Triterpenes Radiation-Sensitizing Agents Histone Deacetylase Inhibitors Indoles Cyclin D1 Hydroxamic Acids Azasteroids TOR Serine-Threonine Kinases bcl-2-Associated X Protein Luciferases Culture Media, Conditioned Membrane Proteins Antibodies, Monoclonal Nuclear Proteins Androstenols beta Catenin Trans-Activators Azacitidine STAT3 Transcription Factor Reactive Oxygen Species Vascular Endothelial Growth Factor A Cyclin-Dependent Kinase Inhibitor p27 Estradiol bcl-X Protein Sodium Selenite Cisplatin Proto-Oncogene Proteins c-myc Oligonucleotides, Antisense Racemases and Epimerases Antibiotics, Antineoplastic Curcumin Estrogen Receptor alpha Androgen-Binding Protein Carrier Proteins Antigens, CD44 Glutathione S-Transferase pi Genistein Matrix Metalloproteinase 9

Analytical, Diagnostic and Therapeutic Techniques and Equipment62

Prostatectomy Xenograft Model Antitumor Assays Orchiectomy Reverse Transcriptase Polymerase Chain Reaction Blotting, Western Neoplasm Transplantation Transplantation, Heterologous Transfection Drug Screening Assays, Antitumor Early Detection of Cancer Immunohistochemistry Gene Expression Profiling Neoplasm Grading Neoplasm Staging Gene Knockdown Techniques Prognosis Flow Cytometry Oligonucleotide Array Sequence Analysis Tumor Burden Digital Rectal Examination Risk Factors Models, Biological Molecular Targeted Therapy Tumor Stem Cell Assay Case-Control Studies Tissue Array Analysis Immunoblotting Castration Transurethral Resection of Prostate Sensitivity and Specificity Risk Survival Rate Survival Analysis Follow-Up Studies Antineoplastic Combined Chemotherapy Protocols Prospective Studies Biopsy Inhibitory Concentration 50 Risk Assessment Genetic Therapy Real-Time Polymerase Chain Reaction Treatment Outcome Retrospective Studies Combined Modality Therapy Immunoenzyme Techniques Biopsy, Needle Immunoprecipitation Odds Ratio Culture Media, Conditioned Incidence Brachytherapy Cohort Studies Polymerase Chain Reaction Disease-Free Survival Disease Models, Animal Reproducibility of Results Multivariate Analysis Predictive Value of Tests Radiotherapy SEER Program Kaplan-Meier Estimate Drug Delivery Systems

Phenomena and Processes49

Gene Expression Regulation, Neoplastic Apoptosis Cell Proliferation Signal Transduction Cell Survival Down-Regulation Cell Growth Processes Cell Division Cell Movement Transfection Drug Resistance, Neoplasm Cell Cycle Up-Regulation RNA Interference Promoter Regions, Genetic Phosphorylation Dose-Response Relationship, Drug Gene Silencing Drug Synergism Genetic Predisposition to Disease Transcription, Genetic Gene Expression Time Factors Base Sequence Enzyme Activation Radiation Tolerance Genes, Tumor Suppressor Transcriptional Activation Mutation Cell Adhesion DNA Methylation Sensitivity and Specificity Risk Cell Death Protein Binding Inhibitory Concentration 50 Genotype Epithelial-Mesenchymal Transition Phenotype Odds Ratio Genes, Neoplasm Gene Fusion MAP Kinase Signaling System Polymorphism, Genetic G1 Phase Cell Cycle Checkpoints Tumor Microenvironment Gene Expression Regulation, Enzymologic Chromosomes, Human, Pair 8

Disciplines and Occupations1

Immunohistochemistry

Anthropology, Education, Sociology and Social Phenomena1

National Cancer Institute (U.S.)

Information Science5

Base Sequence Molecular Sequence Data Survival Rate Incidence SEER Program

Health Care22

Risk Factors Watchful Waiting Case-Control Studies Sensitivity and Specificity Risk Survival Rate Survival Analysis Follow-Up Studies Prospective Studies Risk Assessment Treatment Outcome Retrospective Studies Odds Ratio Incidence Cohort Studies Disease-Free Survival National Cancer Institute (U.S.)Reproducibility of Results Multivariate Analysis Predictive Value of Tests SEER Program Kaplan-Meier Estimate

Geographicals1

Anatomy Organisms Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Phenomena and Processes Disciplines and Occupations Information Science Health Care Geographicals

Prostatic Neoplasms Prostate Cell Line, Tumor Prostate-Specific Antigen Receptors, Androgen Androgens Gene Expression Regulation, Neoplastic Tumor Cells, Cultured Apoptosis Cell Proliferation Androgen Antagonists Neoplasms, Hormone-Dependent Mice, Nude Antineoplastic Agents Neoplasm Invasiveness Tosyl Compounds Prostatectomy Androgen Receptor Antagonists Neoplasm Metastasis Prostatic Hyperplasia Breast Neoplasms Xenograft Model Antitumor Assays Adenocarcinoma Metribolone RNA, Small Interfering Orchiectomy Signal Transduction Reverse Transcriptase Polymerase Chain Reaction Blotting, Western Cell Survival RNA, Messenger Neoplasm Proteins Down-Regulation Anilides Cell Growth Processes Tumor Markers, Biological Bone Neoplasms Cell Division Disease Progression Neoplasm Transplantation Dihydrotestosterone Transplantation, Heterologous Cell Movement Transfection Drug Resistance, Neoplasm Cell Cycle Prostatic Intraepithelial Neoplasia Neoplasms Testosterone Congeners Drug Screening Assays, Antitumor Early Detection of Cancer Up-Regulation Colonic Neoplasms Immunohistochemistry RNA Interference Anticarcinogenic Agents Proto-Oncogene Proteins c-akt Gene Expression Profiling Mice, SCID Antineoplastic Agents, Phytogenic Lung Neoplasms Promoter Regions, Genetic Antineoplastic Agents, Hormonal Carcinoma Ovarian Neoplasms Phosphorylation Neoplasm Grading Neoplasm Staging Dose-Response Relationship, Drug Gene Silencing Glutamate Carboxypeptidase II Gene Knockdown Techniques PTEN Phosphohydrolase Prognosis Tumor Suppressor Protein p53 Flutamide Flow Cytometry Nitriles DNA, Neoplasm Drug Synergism Oligonucleotide Array Sequence Analysis Taxoids Proto-Oncogene Proteins c-bcl-2 Tumor Burden Genetic Predisposition to Disease Pancreatic Neoplasms Transcription, Genetic Transcription Factors Epithelial Cells RNA, Neoplasm Cell Transformation, Neoplastic Caspases Stomach Neoplasms Gene Expression Time Factors Prostatic Neoplasms, Castration-Resistant Enzyme Inhibitors Finasteride Base Sequence Digital Rectal Examination

No FAQ available that match "3 in prostate cancer cells"